Buzzkill Labs Stock

Buzzkill Labs develops and commercializes drug testing for legal cannabis.

Sign up today and learn more about Buzzkill Labs Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Buzzkill Labs Stock

Buzzkill Labs specializes in drug testing for legal cannabis. It develops and commercializes portable, cost-effective testing of oral fluid that distinguishes and measures THC parent compound, the psychoactive component of cannabis that causes impairment. Its technology helps eliminate cheating and determine current potential impairment versus past use with no interference from CBD or metabolites in 15 minutes.

Funding History

November 2021$4.4M

Management

CEO

Jeff Heimburger

Founder, CTO

George Farquar

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo